Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Janice Riley"'
Autor:
Claire Gould, Leisa Jackson, Colin Cochran, Audrey Audetat, Brittany D'Alessio, Amanda Weaver, Janice Riley, Gary A. Pestano
Publikováno v:
Cancer Research. 83:6687-6687
Introduction: Circulating tumor DNA (ctDNA) has emerged as a powerful biomarker with many applications in oncology including early and late-stage disease prognosis and in treatment decision making. Liquid biopsies have become critical in non-small ce
Autor:
Laura Brosh, Bruce L. Dalkin, Kate E. Smith, Dea Nagy, Connie Cortez, Amit M. Algotar, Ubaradka Sathyanarayana, Raymond B. Nagle, Janice Riley, Carol Jones, Ryan Dittamore, Gary Pestano, Steven Yun
Publikováno v:
The Prostate. 73:1233-1240
BACKGROUND This study examines the combined effect of two common genetic alterations, ERG and PTEN, in prostate carcinoma progression. METHODS Prostate tissue from 90 patients having unilateral capsular penetrating lesions, and a contra-lateral organ
Autor:
Ubaradka G. Sathyanarayana, Ashley M Santa-Cruz, Karl Garsha, Theresa Y. MacDonald, Naoki Kitabayashi, Mark A. Rubin, Francesca Demichelis, Gary Pestano, Christopher J. LaFargue, Ashutosh K. Tewari, Dea Nagy, Jerry W. Kosmeder, Janice Riley, Chol S Yun, Maria A. Svensson, Dorothee Pflueger
Publikováno v:
Laboratory Investigation; a Journal of Technical Methods and Pathology
Prostate cancer is a clinically heterogeneous and multifocal disease. More than 80% of patients with prostate cancer harbor multiple geographically discrete cancer foci at the time of diagnosis. Emerging data suggest that these foci are molecularly d
Autor:
Isis C. Sroka, Gerald D. Pond, Raymond B. Nagle, Frank Porreca, Tamara King, Gary Pestano, Bernard W. Futscher, Jaime M. Gard, Janice Riley, Ubaradka G. Sathyanarayana, Anne E. Cress
Publikováno v:
The Open Prostate Cancer Journal. 2:59-66
Existing clinical imaging procedures lack sensitivity and specificity in detecting early prostate cancer bone me- tastatic lesions. In this study, we developed a highly reproducible bone metastasis xenograft model and identified possible molecular im
Autor:
Ian A. Wilson, Bette T. Korber, Janice Riley, Steven M. Wolinsky, Kevin J. Kunstman, Pavel Pugach, Julie M. Strizki, Shawn E. Kuhmann, John P. Moore, Bahige M. Baroudy, Amy Snyder, Joann M. Taylor, Robyn L. Stanfield
Publikováno v:
Journal of Virology. 78:2790-2807
We have described previously the generation of an escape variant of human immunodeficiency virus type 1 (HIV-1), under the selection pressure of AD101, a small molecule inhibitor that binds the CCR5 coreceptor (A. Trkola, S. E. Kuhmann, J. M. Strizki
Autor:
Karlene S. Hosford, William M.o. Boto, Nelson K. Sewankambo, David D. Ho, Jiang Ming Xie, Alexander I. Spira, G. A. Pestano, Janice Riley, Lawrence Brown
Publikováno v:
AIDS Research and Human Retroviruses. 11:589-596
This article describes the impact of sequence variation on the distribution and seroreactivity of linear antigenic epitopes in gp120 encoded in new Ugandan HIV-1 clones from subtypes A, C, and D, and in North American clones from the B subtype. A reg
Autor:
Janice Riley, Eric May, Chris Bieniarz, David Jiang, Ubaradka Sathyanarayana, Phil Miller, Gary Pestano, Jeanne Richard, Raymond B. Nagle, Mark Lefever, Adrian E. Murillo, Jerry Kosmeder, Dea Nagy, Michael Farrell, Ashley Santa-Cruz
Publikováno v:
The FASEB Journal. 23
Autor:
Jerome W. Kosmeder, Gary Pestano, Kristie A. Vanpatten, Julia Ashworth-Sharpe, Anne Carpenter, Mark Lefever, Ned C. Haubein, Chris Bieniarz, Janice Riley, John Palting, Scott Lett, Philip Miller
Publikováno v:
The FASEB Journal. 22
Autor:
Dea Nagy, Michael Otter, Francesca Demichelis, Connie Cortez, Phil Miller, Kassie Smith, Tom Grogan, Ubaradka Sathyanarayana, Krystyn Pozarowski, Raymond Nagle, Gary Pestano, Ryan Dittamore, Steve Yun, Kelly Christopherson, Maria A. Svensson, Janice Riley, Karl Garsha, Nallasivam Palaniswamy, Mark A. Rubin
Publikováno v:
Cancer Research. 71:2218-2218
The identification of patients who will benefit from therapy is one of the more difficult questions in prostate cancer disease management. Approximately 60% of men with diagnosed prostate cancer will have an ETS rearranged tumor foci. The prostate ca
Autor:
Mitchell H. Sokoloff, Mark A. Rubin, Kassie Smith, Krystyn Pozarowski, Ryan Dittamore, Dea Nagy, P Miller, Steven Yun, Nallasivam Palanisamy, Connie C. Cortez, Janice Riley, Kelly Christopherson, Ray B. Nagle, Karl Garsha, Ubaradka G. Sathyanarayana, Gary Pestano, Francesca Demichelis
Publikováno v:
Cancer Research. 71:2227-2227
TMPRSS2:ERG gene rearrangements are an early even found in 50% of prostate cancer patients. Identifcation of men who are at elevated risk of progression from neoplastic PIN (prostatic intraepithelial neoplasia) lesions to prostate carcinoma is an una